Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Enhancing immune response can improve cancer treatment effectiveness.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Androgens increase cervical cancer risk and affect its development.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Immune therapy for cancer can cause hair loss scars in some patients.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.